Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev)

Authors: Taweegrit Siripongboonsitti, Marisa Muadchimkaew, Kriangkrai Tawinprai, Ornisa Issaranon, Wichuda Meepholkij, Pureepat Arttawejkul, Apiradee Vararungzarit, Onwalee Dhissayakamol, Wilaiporn Preeyachit, Kamonwan Soonklang, Nithi Mahanonda

Source: Journal of Virus Eradication, Vol 10, Iss 4, Pp 100576- (2024)

Subject Terms: Household transmission, Favipiravir, Anti-SARS-CoV-2, COVID-19, Secondary infection, Microbiology, QR1-502, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2055664024001912; https://doaj.org/toc/2055-6640

Access URL: https://doaj.org/article/104027347d434bca977f7109ece306c9

A randomized trial to assess the acceleration of viral clearance by the combination Favipiravir/Ivermectin/Niclosamide in mild-to-moderate COVID-19 adult patients (FINCOV)

Authors: Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Panisadee Avirutnan, Kunlakanya Jitobaom, Prasert Auewarakul

Source: Journal of Infection and Public Health, Vol 17, Iss 5, Pp 897-905 (2024)

Subject Terms: Favipiravir, Ivermectin, Niclosamide, COVID-19, SARS-CoV-2, Infectious and parasitic diseases, RC109-216, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1876034124001060; https://doaj.org/toc/1876-0341

Access URL: https://doaj.org/article/60ae10a978e145a6b07adecdb6ef3723

Unveiling therapeutic dynamics: An in-depth comparative analysis of neutralizing monoclonal antibodies and favipiravir in alleviating COVID-19 outpatients impacts among middle-aged and special populations (MA-FAST)

Authors: Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Thachanun Porntharukcharoen, Supamas Sirisreetreerux, Thitapha Thongchai, Kamonwan Soonklang, Nithi Mahanonda

Source: Journal of Infection and Public Health, Vol 17, Iss 7, Pp 102471- (2024)

Subject Terms: Favipiravir, COVID-19, SARS-CoV-2, Neutralizing monoclonal antibody, Sotrovimab, Casirivimab/ imdevimab, Infectious and parasitic diseases, RC109-216, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1876034124002053; https://doaj.org/toc/1876-0341

Access URL: https://doaj.org/article/b1d68159212648619f06ac2992b72cf0

The real-world effectiveness of fluvoxamine therapy in mild to moderate COVID-19 patients; A historical cohort study (Fluvoxa Trial)

Authors: Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Paruspak Payoong, Nithi Mahanonda

Source: Journal of Infection and Public Health, Vol 16, Iss 12, Pp 2010-2016 (2023)

Subject Terms: Fluvoxamine, Favipiravir, COVID-19, SARS-CoV-2, SSRI, Infectious and parasitic diseases, RC109-216, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1876034123003374; https://doaj.org/toc/1876-0341

Access URL: https://doaj.org/article/c4d20189180446a394ad9b6d69381a21

Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand

Authors: Nicolas Salvadori, Gonzague Jourdain, Rungroj Krittayaphong, Taweegrit Siripongboonsitti, Subsai Kongsaengdao, Kriangsak Atipornwanich, Parichart Sakulkonkij, Nasikarn Angkasekwinai, Rujipas Sirijatuphat, Sarunyou Chusri, Tanavit Mekavuthikul, Anucha Apisarnthanarak, Sirawat Srichatrapimuk, Somnuek Sungkanuparph, Suppachok Kirdlarp, Thanyakamol Phongnarudech, Suraphan Sangsawang, Panuwat Napinkul, Jullapong Achalapong, Suwimon Khusuwan, Piyanut Pratipanawat, Pornboonya Nookeu, Namphol Danpipat, Pornvimol Leethong, Piya Hanvoravongchai, Pra-ornsuda Sukrakanchana, Prasert Auewarakul

Source: International Journal of Infectious Diseases, Vol 143, Iss , Pp 107021- (2024)

Subject Terms: Molnupiravir, Favipiravir, COVID-19, Outpatients, Randomized controlled trial, Thailand, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1201971224000924; https://doaj.org/toc/1201-9712

Access URL: https://doaj.org/article/972cd2cefc9d4bcba14963dedb5e4831

Efficacy of combination therapy of fluvoxamine and favipiravir vs favipiravir monotherapy to prevent severe COVID-19 among mild to moderate COVID-19 patients: Open-label randomized controlled trial (EFFaCo study)

Authors: Taweegrit Siripongboonsitti, Teerapat Ungtrakul, Kriangkrai Tawinprai, Tararin Nimmol, Mullika Buttakosa, Gaidganok Sornsamdang, Tanadul Jarrusrojwuttikul, Phumin Silapant, Nithi Mahanonda

Source: International Journal of Infectious Diseases, Vol 134, Iss , Pp 211-219 (2023)

Subject Terms: Fluvoxamine, Favipiravir, COVID-19, SARS-CoV-2, SSRI, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1201971223006410; https://doaj.org/toc/1201-9712

Access URL: https://doaj.org/article/7ea8cdad9a994bf7b265475b19f6c888

Favipiravir treatment in non-severe COVID-19: promising results from multicenter propensity score-matched study (FAVICOV)

Authors: Taweegrit Siripongboonsitti, Marisa Muadchimkaew, Kriangkrai Tawinprai, Ornisa Issaranon, Wichuda Meepholkij, Pureepat Arttawejkul, Apiradee Vararungzarit, Kaewklao Thavornwattana, Nithi Mahanonda

Source: Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/5e0a417ce98a4f85b751fd317d7f60e4

Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab)

Authors: Taweegrit Siripongboonsitti, Nuttakant Nontawong, Kriangkrai Tawinprai, Ornpreya Suptawiwat, Kamonwan Soonklang, Yong Poovorawan, Nithi Mahanonda

Source: Microbiology Spectrum, Vol 11, Iss 6 (2023)

Subject Terms: convalescent plasma, sotrovimab, monoclonal antibody, mild COVID-19, SARS-CoV-2, randomized controlled trial, Microbiology, QR1-502

File Description: electronic resource

Relation: https://doaj.org/toc/2165-0497

Access URL: https://doaj.org/article/2ce1f18101794cd081442a6408dd08c4

The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case–control study

Authors: Nuttakant Nontawong, Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Mana Boonpratoom, Nawin Krailassiri, Chayaporn Boonkhum, Kamonwan Soonklang, Yong Poovorawan, Nithi Mahanonda

Source: Annals of Clinical Microbiology and Antimicrobials, Vol 21, Iss 1, Pp 1-9 (2022)

Subject Terms: COVID-19, Convalescent plasma, Severe COVID-19, Mortality, Therapeutics. Pharmacology, RM1-950, Infectious and parasitic diseases, RC109-216, Microbiology, QR1-502

File Description: electronic resource

Relation: https://doaj.org/toc/1476-0711

Access URL: https://doaj.org/article/333418eb6d0445778dead8320a018168

Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial)

Authors: Marisa Muadchimkaew, Taweegrit Siripongboonsitti, Saowanee Wongpatcharawarakul, Chanyapak Boonsankaew, Kriangkrai Tawinprai, Kamonwan Soonklang, Nithi Mahanonda

Source: International Journal of Infectious Diseases, Vol 124, Iss , Pp 190-198 (2022)

Subject Terms: Inactivated vaccine, SARS-CoV-2, COVID-19, ChAdOx1 nCOV-19, Household transmission, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1201971222005318; https://doaj.org/toc/1201-9712

Access URL: https://doaj.org/article/4d3f38d8634044dea60757ca02375555

The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study

Authors: Thachanun Porntharukchareon, Wipada Chartisathian, Manassamon Navinpipat, Chayanee Samdaengpan, Kunsuda Cheirsilpa, Aimwipa Lueprasitsakul, Supanat Worawichawong, Viroj Muangsillapasart, Pratya Pumuthaivirat, Bothamai Dechates, Supamas Sirisreetreerux, Taweegrit Siripongboonsitti, Vimonsri Rangsrisaeneepitak, Kerati Jirawattanapalin, Kriangkrai Tawinprai

Source: Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)

Subject Terms: chadox1 ncov-19, vaccine, comorbidity, immunogenicity, covid-19, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/d9fefc7a82fe41f29f104928efe1ccb9

Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study

Authors: Kriangkrai Tawinprai, Pawornrath Jungsomsri, Onnicha Pinijnai, Fahsiri Tavonvunchai, Anchisa Lievjaroen, Paphada Suwannaroj, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Gaidganok Sornsamdang, Teerapat Ungtrakul

Source: Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)

Subject Terms: covid-19, heterologous prime-boost, vaccine combination, chadox1 ncov-19, azd1222, coronavac, bbibp-corv, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/42c6891d29e742938839e6dc6ce95afb

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

Authors: Guy Cohen, Pawornrath Jungsomsri, Jirath Sangwongwanich, Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda

Source: Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)

Subject Terms: covid-19, heterologous prime-boost, vaccine combination, chadox1 ncov-19, azd1222, coronavac, immunogenicity, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/ace75072a2284f9c82835fe675893969

The Real-World Clinical Outcomes of Favipiravir Treatment with Telemedicine Monitoring in Preventing Disease Progression in Mild to Moderate COVID-19 Patients; A Retrospective Cohort Study

Authors: Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Kunsuda Cheirsilpa, Teerapat Ungtrakul, Wasanai Krisorakun, Chanisa Chotipanich, Nat Wimolsiri, Permpen Noitun, Netnapis Srirattana, Nithi Mahanonda

Source: Medicina, Vol 59, Iss 6, p 1098 (2023)

Subject Terms: COVID-19, SARS-CoV-2, telemedicine, telehealth, favipiravir, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/59/6/1098; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/7af3600f5a2c481dba67e1f248801fa8

Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population

Authors: Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Bothamai Dechates, Harnphadungkit Monprach, Gaidganok Sornsamdang, Kasiruck Wittayasak, Kamonwan Soonklang, Nithi Mahanonda

Source: Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)

Subject Terms: chadox1, azd1222, covid-19 vaccine, single-dose vaccine, immunogenicity, safety, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/a41548c39fc9479697ac78e94bb2efbd

Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study

Authors: Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Preeda Vanichsetakul, Saraiorn Thonginnetra, Krongkwan Niemsorn, Pathariya Promsena, Manunya Tandhansakul, Naruporn Kasemlawan, Natthanan Ruangkijpaisal, Narin Banomyong, Nanthida Phattraprayoon, Teerapat Ungtrakul, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Nithi Mahanonda

Source: Vaccines, Vol 10, Iss 5, p 807 (2022)

Subject Terms: COVID-19, SARS-CoV-2, adolescent, BBIBP-CorV, safety, immunogenicity, Medicine

File Description: electronic resource

Relation: https://www.mdpi.com/2076-393X/10/5/807; https://doaj.org/toc/2076-393X

Access URL: https://doaj.org/article/f0920593e03b44738a226c8837f086c0

Community-Acquired Monomicrobial Pseudomonas aeruginosa Necrotizing Fasciitis: A Case Report.

Authors: Taweegrit Siripongboonsitti

Source: Journal of the Medical Association of Thailand; 2018 Supplement, Vol. 101, pS193-S198, 6p

Subject Terms: FASCIITIS, SOFT tissue infections, HEMODYNAMICS, PSEUDOMONAS aeruginosa, DOCETAXEL

This result is not displayed to guests.
Login for full access.